Jan 31, 2020 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Jubilant Life Sciences Limited Q3 and 9-month FY '20 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Ravi Agrawal, Head of Investor Relations. Thank you, and over to you, sir.
Ravi Agrawal - Jubilant Life Sciences Limited - Head of IR
Thank you. Good evening, everybody. I'm Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences. I thank you again for being with us today on our Q3 and 9 months FY '20 earnings conference call.
I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.
On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. R. Sankaraiah, Executive Director of Finance; Mr. Alok Vaish, CFO Designate; Mr. Pramod Yadav, CEO, Jubilant Pharma; and Mr.
Q3 2020 Jubilant Life Sciences Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot